What Are the Long-Term Safety Considerations for Combined NAD+ Precursor and Growth Hormone Peptide Therapies?
Combined NAD+ precursor and growth hormone peptide therapies require vigilant, long-term monitoring for metabolic, endocrine, and oncological adaptations.
HRTioAugust 24, 2025